Frontiers in medicine · 2025
Increased risk of skin cancers in mucous membrane pemphigoid: a large-scale matched cohort study of 117 million US individuals.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nouri Amar, Olbrich Henning, Schmidt Enno, Ludwig Ralf J, Curman Philip
Аннотация
INTRODUCTION: Mucous membrane pemphigoid (MMP) is an autoimmune disease affecting the oral mucosa, conjunctivae and other mucous membranes. The mainstay treatment options are local and systemic corticosteroids and immunomodulatory therapies. Current research on cancer risk in MMP is scarce and has yielded conflicting results.
METHODS: The aim of this study was to investigate the risk of developing skin cancer in patients with MMP by performing a large-scale, retrospective matched cohort study utilizing data from over 117 million US individuals. The risk of skin cancer in patients with MMP was observed within a 5-year follow-up period, along with three temporal difference analyses and stratification for disease severity.
RESULTS: MMP was associated with an increased risk of several types of skin cancers within the first 5 years of follow-up, particularly squamous cell carcinoma, basal cell carcinoma, and non-melanoma skin cancer. Stratification by disease severity showed significantly elevated risks in severe cases.
DISCUSSION: These findings underscore the importance of regular skin cancer screening and risk-based monitoring in MMP patients, particularly those with severe disease. Integrating dermatologic surveillance into routine care could facilitate early detection and timely intervention. Additionally, these results highlight the need for further research into cancer risks in other autoimmune blistering diseases, helping to refine long-term management strategies.
METHODS: The aim of this study was to investigate the risk of developing skin cancer in patients with MMP by performing a large-scale, retrospective matched cohort study utilizing data from over 117 million US individuals. The risk of skin cancer in patients with MMP was observed within a 5-year follow-up period, along with three temporal difference analyses and stratification for disease severity.
RESULTS: MMP was associated with an increased risk of several types of skin cancers within the first 5 years of follow-up, particularly squamous cell carcinoma, basal cell carcinoma, and non-melanoma skin cancer. Stratification by disease severity showed significantly elevated risks in severe cases.
DISCUSSION: These findings underscore the importance of regular skin cancer screening and risk-based monitoring in MMP patients, particularly those with severe disease. Integrating dermatologic surveillance into routine care could facilitate early detection and timely intervention. Additionally, these results highlight the need for further research into cancer risks in other autoimmune blistering diseases, helping to refine long-term management strategies.